Coherus BioSciences Statistics
Total Valuation
CHRS has a market cap or net worth of $231.54 million. The enterprise value is $593.62 million.
| Market Cap | 231.54M |
| Enterprise Value | 593.62M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRS has 113.50 million shares outstanding. The number of shares has increased by 21.30% in one year.
| Shares Outstanding | 113.50M |
| Shares Change (YoY) | +21.30% |
| Shares Change (QoQ) | +14.40% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 77.28% |
| Float | 103.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | 0.88 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43
| Current Ratio | 1.43 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.60% |
| Return on Capital (ROIC) | -71.23% |
| Revenue Per Employee | $840,667 |
| Profits Per Employee | -$777,425 |
| Employee Count | 306 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.30 |
Taxes
| Income Tax | -380,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.84% in the last 52 weeks. The beta is 0.51, so CHRS's price volatility has been lower than the market average.
| Beta (1Y) | 0.51 |
| 52-Week Price Change | -72.84% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 3.11 |
| Relative Strength Index (RSI) | 41.03 |
| Average Volume (30 Days) | 2,718,162 |
Short Selling Information
The latest short interest is 21.53 million, so 18.97% of the outstanding shares have been sold short.
| Short Interest | 21.53M |
| Short Previous Month | 23.45M |
| Short % of Shares Out | 18.97% |
| Short % of Float | 20.73% |
| Short Ratio (days to cover) | 8.97 |
Income Statement
In the last 12 months, CHRS had revenue of $257.24 million and -$237.89 million in losses. Loss per share was -$2.53.
| Revenue | 257.24M |
| Gross Profit | 98.25M |
| Operating Income | -203.20M |
| Pretax Income | -238.27M |
| Net Income | -237.89M |
| EBITDA | -191.46M |
| EBIT | -197.73M |
| Loss Per Share | -$2.53 |
Balance Sheet
The company has $117.75 million in cash and $478.70 million in debt, giving a net cash position of -$360.95 million or -$3.18 per share.
| Cash & Cash Equivalents | 117.75M |
| Total Debt | 478.70M |
| Net Cash | -360.95M |
| Net Cash Per Share | -$3.18 |
| Equity / Book Value | -193.43M |
| Book Value Per Share | -1.70 |
| Working Capital | 143.86M |
Cash Flow
In the last 12 months, operating cash flow was -$174.88 million and capital expenditures $559,000, giving a free cash flow of -$174.33 million.
| Operating Cash Flow | -174.88M |
| Capital Expenditures | 559,000 |
| Free Cash Flow | -174.33M |
| FCF Per Share | -$1.85 |
Margins
Gross margin is 38.19%, with operating and profit margins of -78.99% and -92.48%.
| Gross Margin | 38.19% |
| Operating Margin | -78.99% |
| Pretax Margin | -92.62% |
| Profit Margin | -92.48% |
| EBITDA Margin | -74.43% |
| EBIT Margin | -76.86% |
| FCF Margin | -67.77% |
Dividends & Yields
CHRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.30% |
| Shareholder Yield | -21.30% |
| Earnings Yield | -102.24% |
| FCF Yield | -74.92% |
Analyst Forecast
The average price target for CHRS is $8.75, which is 328.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.75 |
| Price Target Difference | 328.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 26.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CHRS has an Altman Z-Score of -3.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.7 |
| Piotroski F-Score | 2 |